The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 201–300 of 1,388
Ducluzeau, P., Cousin, P., Malvoisin, E., Bornet, H., Vidal, H., Laville, M., & PUGEAT, M. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030219 · Cited by 137
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135
Trikudanathan, S. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.003 · Cited by 140
Effects of lifestyle modification in polycystic ovarian syndrome
Moran, L., Brinkworth, G. D., Noakes, M., & Norman, R. J. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61182-0 · Cited by 136
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
The adrenal and polycystic ovary syndrome
Yıldız, B. O., & Azziz, R. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9054-0 · Cited by 135
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., Adams, J. M., Hwang, C. H., Hall, J. E., & Sachs, G. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.017 · Cited by 134
Relationships between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary Syndrome
Tasali, E., Cauter, E. V., & Ehrmann, D. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1084 · Cited by 136
Tomlinson, J., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 132
Niu, Z., Lin, N., Gu, R., Sun, Y., & Feng, Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3942 · Cited by 129
Role of obesity and adiposity in polycystic ovary syndrome
Diamanti‐Kandarakis, E. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803730 · Cited by 129
Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance
Sepilian, V., & Nagamani, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1376 · Cited by 130
Skeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
Spranger, J., Möhlig, M., Wegewitz, U. E., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Brabant, G. E., & Schöfl, C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02159.x · Cited by 130
Colilla, S., Cox, N. J., & Ehrmann, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7518 · Cited by 130
Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance
Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., Chang, R. J., & Henry, R. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1492 · Cited by 130
Polycystic ovary syndrome and impact on health
Allahbadia, G. N., & Merchant, R. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.002 · Cited by 127
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
Bridger, T., MacDonald, S., Baltzer, F., & Rodd, C. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.3.241 · Cited by 126
Bird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M., & Delaney, J. A. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120677 · Cited by 126
Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126
Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
Setji, T. L., & Brown, A. J. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.017 · Cited by 127
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
Recabarren, S. E., Smith, R., Ríos, R., Maliqueo, M. A., Echiburú, B., Ethel Codner, D., CASSORLA, F. G., Rojas, P., & Sir‐Petermann, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2256 · Cited by 126
Clinical and laboratory diagnosis of the metabolic syndrome
Olufadi, R., & Byrne, C. D. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048363 · Cited by 123
Schmidt, J., Weijdegård, B., Mikkelsen, A., Lindenberg, S., Nilsson, L., & Brännström, M. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat051 · Cited by 123
Tasali, E., Chapotot, F., Leproult, R., Whitmore, H. R., & Ehrmann, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1187 · Cited by 127
Chan, C. C. W., Koo, M. W. L., Ng, E. H. Y., Tang, O., Yeung, W. S. B., & Ho, P. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.10.006 · Cited by 124
Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02208.x · Cited by 119
The genetics of polycystic ovary syndrome
Amato, P., & Simpson, J. L. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.002 · Cited by 122
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
Dunaif, A. E. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0787 · Cited by 122
Self-citationCriteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Alsamarai, S., Adams, J. M., Murphy, M. K., Post, M. D., Hayden, D. L., Hall, J. E., & Welt, C. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0839 · Cited by 122
Pall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123
Weerakiet, S., Srisombut, C., Bunnag, P., Sangtong, S., Chuangsoongnoen, N., & Rojanasakul, A. (2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(01)00477-5 · Cited by 119
Diagnosis of Polycystic Ovary Syndrome
Trivax, B., & Azziz, R. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f351b · Cited by 120
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
Leibel, N. I., Baumann, E. E., Kocherginsky, M., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1707 · Cited by 118
Type 2 Diabetes Mellitus in Youth: The Complete Picture to Date
Gungor, N., Hannon, T. S., Libman, I. M., Bacha, F. F., & Arslanian, S. A. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.009 · Cited by 116
Use of clomiphene citrate in infertile women: a committee opinion
(2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.033 · Cited by 124
The effects of old, new and emerging medicines on metabolic aberrations in PCOS
Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 120
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117
Jensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T., & Janez, A. (2015) · Hormones · doi:10.1007/bf03401383 · Cited by 117
The importance of insulin resistance in polycystic ovary syndrome
Goodarzi, M. O., & Korenman, S. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00734-9 · Cited by 118
Samy, N., Hashim, M., Sayed, M., & Said, M. (2009) · Disease Markers · doi:10.1155/2009/465203 · Cited by 141
Ibáñez, L., Potau, N., Marcos, M. V., & de Zegher, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6814 · Cited by 117
Li, H., Huang, X. Y., Chang, X., Yao, J., He, Q., Shen, Z., Ji, Y., & Wang, K. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14642 · Cited by 115
Vgontzas, A. N., Trakada, G., Bixler, E. O., Lin, H.-M., Pejovic, S., Zoumakis, E., Chrousos, G. P., & Legro, R. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.002 · Cited by 114
Self-citationOn the Association Between Valproate and Polycystic Ovary Syndrome
Genton, P., Bauer, J. M., Duncan, S., Taylor, A. E., Balen, A. H., Eberle, A., Pedersen, B., Salas‐Puig, X., & Sauer, M. V. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.28899.x · Cited by 114
Urbanek, M., Sam, S., Legro, R. S., & Dunaif, A. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0761 · Cited by 115
Self-citationCardiovascular Risk In Women With Polycystic Ovary Syndrome
Talbott, E. O., Zborowski, J. V., Sutton-Tyrrell, K., McHugh-Pemu, K. P., & Guzick, D. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70189-3 · Cited by 113
The Metabolic Syndrome in Polycystic Ovary Syndrome
Essah, P. A., Wickham, E. P., & Nestler, J. E. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f3547 · Cited by 113
Lo, J. C., Feigenbaum, S. L., Escobar, G. J., Yang, J., Crites, Y. M., & Ferrara, A. (2006) · Diabetes Care · doi:10.2337/dc06-0877 · Cited by 112
Villuendas, G., Millán, J. L. S., Sancho, J., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8309 · Cited by 116
Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.037 · Cited by 111
Self-citationAbnormal glucose tolerance in Chinese women with polycystic ovary syndrome
Chen, X., Yang, D., Li, L., Feng, S., & Wang, L. (2006) · Human Reproduction · doi:10.1093/humrep/del142 · Cited by 112
Goodman, N. F., Bledsoe, M. B., Cobin, R. H., Futterweit, W., Goldzieher, J. W., Petak, S. M., Smith, K. D., Steinberger, E., Anderson, R. J., Bergman, D. A., et al. (2001) · Endocrine Practice · doi:10.4158/ep.7.2.120 · Cited by 111
Insulin-sensitizing agents in polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02156 · Cited by 112
Bunn, F., Kirby, M. G., Pinkney, E., Cardozo, L., Chapple, C. R., Chester, K., Cruz, F., Haab, F., Kelleher, C. J., Milsom, I., et al. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12518 · Cited by 115
Kort, D. H., & Lobo, R. A. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.05.009 · Cited by 120
Polycystic ovary syndrome and infertility: an update
Zehravi, M., Maqbool, M., & Ara, I. (2021) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2021-0073 · Cited by 124
Polycystic ovary syndrome: A risk for coronary artery disease?
Wild, R. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119180 · Cited by 109
Tasali, E., Van Cauter, E., Hoffman, L., & Ehrmann, D. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0925 · Cited by 111
Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth
Harwood, K., Vuguin, P. M., & DiMartino-Nardi, J. (2007) · Hormone Research in Paediatrics · doi:10.1159/000101538 · Cited by 109
Siegel, S., Futterweit, W., Davies, T. F., Concepcion, E., Greenberg, D. A., Villanueva, R., & Tomer, Y. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04241-3 · Cited by 109
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
Polycystic Ovary Syndrome and Obstructive Sleep Apnea
Tasali, E., Cauter, E. V., & Ehrmann, D. A. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.11.001 · Cited by 111
Polycystic Ovary Syndrome: Definitions, Phenotypes and Diagnostic Approach
Livadas, S., & Diamanti‐Kandarakis, E. (2012) · Frontiers of hormone research · doi:10.1159/000341673 · Cited by 112
PCOS and Depression: Common Links and Potential Targets
Kolhe, J. V., Chhipa, A. S., Butani, S., Chavda, V. K., & Patel, S. S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00765-2 · Cited by 126
Thatcher, S. S., & Jackson, E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.047 · Cited by 108
Longterm management of Polycystic Ovarian Syndrome (PCOS)
Bates, G. W., & Legro, R. S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.029 · Cited by 106
Self-citationFTO and MC4R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome
Ewens, K. G., Jones, M. R., Ankener, W., Stewart, D. R., Urbanek, M., Dunaif, A. E., Legro, R. S., Chua, A. K., Azziz, R., Spielman, R. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016390 · Cited by 105
Self-citationPolycystic ovarian disease: heritability and heterogeneity
Crosignani, P. G. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.1.3 · Cited by 107
Wiltgen, D., & Spritzer, P. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.015 · Cited by 105
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K., Mastorakos, G. P., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 112
Bhattacharya, S. M., & Jha, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.035 · Cited by 103
Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS)
Rutkowska, A. Z., & Rachoń, D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.871517 · Cited by 108
Cobin, R. H., Futterweit, W., Nestler, J. E., Reaven, G. M., Jellinger, P. S., Handelsman, Y., Redmond, G. P., & Thatcher, S. S. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.125 · Cited by 105
Relationship of Calpain-10 Genotype to Phenotypic Features of Polycystic Ovary Syndrome
Ehrmann, D. A., Schwarz, P. E. H., Hara, M., Tang, X. A., Horikawa, Y., Imperial, J., Bell, G. I., & Cox, N. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8385 · Cited by 109
Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review
Tabrizi, F. P. F., Hajizadeh‐Sharafabad, F., Vaezi, M., Vayghan, H. J., Alizadeh, M., & Maleki, V. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-0616-z · Cited by 106
Rajendran, S., Willoughby, S. R., Chan, W. P. A., Liberts, E. A., Heresztyn, T., Saha, M., Marber, M. S., Norman, R. J., & Horowitz, J. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.010 · Cited by 104
Obesity and Weight Loss in Polycystic Ovary Syndrome
Hoeger, K. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70187-x · Cited by 103
Halperin, I. J., Kumar, S. S., Stroup, D. F., & Laredo, S. (2010) · Human Reproduction · doi:10.1093/humrep/deq301 · Cited by 100
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Livadas, S., Anagnostis, P. G., Bosdou, J. Κ., Bantouna, D., & Paparodis, R. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i1.5 · Cited by 111
Fertility Issues in Women with Diabetes
Livshits, A., & Seidman, D. S. (2009) · Women s Health · doi:10.2217/whe.09.47 · Cited by 102
Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome
BROWN, A. J., SETJI, T. L., SANDERS, L. L., LOWRY, K. P., OTVOS, J. D., KRAUS, W. E., & SVETKEY, P. L. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31818c6c0c · Cited by 101
Mechanisms of intergenerational transmission of polycystic ovary syndrome
Dumesic, D. A., Hoyos, L. R., Chazenbalk, G. D., Naik, R., Padmanabhan, V., & Abbott, D. H. (2020) · Reproduction · doi:10.1530/rep-19-0197 · Cited by 101
Ehrmann, D. A., Tang, X. A., Yoshiuchi, I., Cox, N. J., & Bell, G. I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020216 · Cited by 99
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub4 · Cited by 104
Dyslipidemia and Metabolic Syndrome in the Sisters of Women with Polycystic Ovary Syndrome
Sam, S., Legro, R. S., Bentley–Lewis, R., & Dunaif, A. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2217 · Cited by 101
Self-citationPolycystic ovaries in hirsute women with normal menses
Carmina, E., & Løbo, R. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00979-2 · Cited by 101
Diao, F., Xu, M., Hu, Y., Li, J., Xu, Z., Lin, M., Wang, L., Zhou, Y., Zhou, Z., Liu, J., et al. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330059 · Cited by 99
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
Goodarzi, M. O., Erickson, S. W., Port, S. C., Jennrich, R. I., & Korenman, S. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1006 · Cited by 99
Sir‐Petermann, T., Bárbara Angel, B., Maliqueo, M. A., Carvajal, F., Santos, J. L., & Pérez-Bravo, F. (2002) · Diabetologia · doi:10.1007/s00125-002-0836-3 · Cited by 99
Role of Oxidative Stress in Polycystic Ovary Syndrome
Lee, J. Y., Baw, C., Gupta, S., Aziz, N., & Agarwal, A. K. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321336 · Cited by 99
TNF- and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study
Escobar-Morreale, H. F., Calvo, R. M., Sancho, J., & Millán, J. L. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7770 · Cited by 104
Luque‐Ramírez, M., Álvarez‐Blasco, F., Botella-Carretero, J. I., Martínez‐Bermejo, E., Lasunción, M. A., & Escobar-Morreale, H. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0282 · Cited by 96
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
Palmert, M. R., Gordon, C. M., Kartashov, A. I., Legro, R. S., Emans, S. J., & Dunaif, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8305 · Cited by 354
Self-citationDermatologic Manifestations of Polycystic Ovary Syndrome
Lee, A. T., & Zane, L. T. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708040-00003 · Cited by 98
Sam, S., Legro, R. S., Essah, P. A., Apridonidze, T., & Dunaif, A. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602025103 · Cited by 96
Self-citationFaloia, E., Canibus, P., Gatti, C., Frezza, F., Santangelo, M., Garrapa, G., & Boscaro, M. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345285 · Cited by 96
Gao, L., Gu, Y., & Yin, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164021 · Cited by 99
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
